In the beautifully complex world of breast milk, research continues to uncover vital components that serve to nourish and protect infants. Among these crucial components, human milk oligosaccharides (HMOs) have emerged as pivotal players. HMOs, intricate sugars found abundantly and diversely in breast milk, have been shown to serve several roles ranging from nurturing beneficial intestinal bacteria to directly modulating immune responses.

‍

The Composition of HMOs: A Rich Sugar Symphony

‍

Breast milk is a rich reservoir of over 200 different types of oligosaccharides, including lacto-N-biose subunits, N-acetyllactosamine disaccharide units, fucose, and sialic acid residues. HMOs, crafted from five monosaccharide building blocks, exhibit variance in size, structure, and complexity. Interestingly, the composition of HMO in breast milk not only varies among lactating mothers but is also significantly impacted by maternal genetics, giving rise to four distinct milk groups.

‍

Despite the complexity, advancements in analytical tools have enabled researchers to precisely differentiate and quantify these milk glycans, enabling a deeper exploration into their relationship with early-life intestinal development. 

‍

The Biological Role of HMOs

‍

Studies suggest that many infant gut bacteria are naturally equipped to consume HMOs, which explains their dominance in the gut of breast-fed infants. They serve as prebiotic components providing the necessary metabolic substrates for beneficial bacteria to thrive. 

‍

Apart from this, HMOs also serve as soluble decoy receptors improving gut barrier function, promoting immune development, modulating intestinal cell responses, and reducing the risk of necrotizing enterocolitis. The diverse protective roles HMOs play on an infant's development are as varied as their structural composition. 

‍

Anti-Infective Properties of HMOs

‍

HMOs are believed to confer a selective advantage to beneficial microbes over pathogens and block pathogenic entry by acting as soluble receptor decoys. They have been shown to provide protection against a wide spectrum of pathogens, including bacteria such as Campylobacter jejuni, Escherichia coli, and viruses such as human immunodeficiency virus (HIV). Recent studies suggest potential anti-viral properties against coronaviruses including SARS-CoV-2. Additionally, they have been reported to reduce fungal and protozoan parasite infections. 

‍

HMOs and Gut Health

‍

The impact of HMOs is not restricted to fighting infections. They have been found to play a crucial role in enhancing the gut's barrier function, reducing cell proliferation and promoting cell differentiation. They also modify gene expression on the epithelial surface and enhance the stability of the glycocalyx, an external layer of cells, which in turn reduces the adherence of pathogenic bacteria. 

‍

Impact on Immune Responses

‍

HMOs are also thought to modulate neonatal innate immune responses by controlling the expression of inflammatory markers and affecting cytokine and chemokine networks that regulate the balance of Th1/Th2 lymphocytes. 

‍

Evidence suggests that HMOs can reduce the levels of pro-inflammatory cytokines and increase the expression of cytokines associated with tissue repair and homeostasis. Animal model studies have also demonstrated that HMOs could be protective against the development of type-1 diabetes, suggesting a therapeutic potential in the treatment of gut-related autoimmune diseases. 

‍

Closing Thoughts

‍

In conclusion, HMOs, the complex sugars present in breast milk, play a crucial role in shaping the infant gut microbiota and supporting health. They promote healthy microbial diversity, prevent pathogen attachment, stimulate maturation of the intestinal epithelial surface, and modulate immune cells. While these are all compelling reasons to promote breastfeeding, it's essential to acknowledge that for some mothers, breastfeeding may not be an option. 

‍

As research continues to uncover the pivotal role of HMOs, the development and supplementation of infant formula with commercially available oligosaccharides can help narrow the compositional gap between human milk and formula milk, offering an alternative for those unable to breastfeed.

‍

Though more large-scale clinical studies are needed to fully elucidate the mechanistic link between HMOs and infant intestinal health, it is clear that the impact of these sweet molecules on infant health is profound and multifaceted.

‍

This blog post was inspired by this paper.

‍